Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
62.79
+0.92 (1.49%)
Aug 13, 2025, 4:00 PM - Market closed
ANSYS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 2,626 | 2,519 | 1,568 | 1,023 | 958.1 | 789.04 | Upgrade | |
Revenue Growth (YoY) | 17.44% | 60.62% | 53.34% | 6.76% | 21.43% | 0.47% | Upgrade |
Cost of Revenue | 863.99 | 819.88 | 476.52 | 262.83 | 239.22 | 217.46 | Upgrade |
Gross Profit | 1,762 | 1,699 | 1,092 | 760.01 | 718.88 | 571.58 | Upgrade |
Selling, General & Admin | 1,039 | 977.48 | 643.41 | 432.12 | 408.15 | 354.76 | Upgrade |
Research & Development | 140.86 | 161.6 | 124.01 | 73.02 | 97.35 | 84.52 | Upgrade |
Operating Expenses | 1,299 | 1,258 | 818.45 | 522.87 | 524.02 | 456.11 | Upgrade |
Operating Income | 463.84 | 441.03 | 273.51 | 237.15 | 194.86 | 115.47 | Upgrade |
Interest Expense | - | -4.19 | - | - | - | - | Upgrade |
Interest & Investment Income | 2.41 | - | 20.13 | 14.23 | 9.3 | 13.95 | Upgrade |
Currency Exchange Gain (Loss) | -22.9 | -43.29 | 14.26 | -1.02 | -1.42 | -0.28 | Upgrade |
Other Non Operating Income (Expenses) | 0.94 | 1.57 | -1.35 | 7.24 | 3.36 | 1.38 | Upgrade |
EBT Excluding Unusual Items | 444.29 | 395.12 | 306.55 | 257.6 | 206.09 | 130.53 | Upgrade |
Merger & Restructuring Charges | -182.04 | -274.72 | -139.93 | -6.85 | -16.98 | -4.03 | Upgrade |
Gain (Loss) on Sale of Investments | 1.04 | 0.64 | -0.79 | -5.39 | -2.78 | -0.59 | Upgrade |
Legal Settlements | -0.31 | -0.31 | -0.43 | -2.34 | -5.92 | -0.01 | Upgrade |
Other Unusual Items | 110.56 | - | - | - | - | - | Upgrade |
Pretax Income | 373.54 | 120.72 | 165.39 | 243.02 | 180.41 | 125.9 | Upgrade |
Income Tax Expense | 16.89 | 17.74 | 42.52 | 52.85 | 31.22 | 23.61 | Upgrade |
Net Income | 356.65 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade |
Net Income to Common | 356.65 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade |
Net Income Growth | 776.83% | -16.19% | -35.39% | 27.47% | 45.86% | -34.10% | Upgrade |
Shares Outstanding (Basic) | 136 | 136 | 113 | 100 | 101 | 99 | Upgrade |
Shares Outstanding (Diluted) | 139 | 138 | 115 | 103 | 104 | 101 | Upgrade |
Shares Change (YoY) | 4.89% | 20.27% | 11.68% | -0.95% | 2.63% | -1.01% | Upgrade |
EPS (Basic) | 2.62 | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 | Upgrade |
EPS (Diluted) | 2.57 | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 | Upgrade |
EPS Growth | 745.36% | -29.91% | -42.16% | 28.47% | 42.57% | -33.55% | Upgrade |
Free Cash Flow | 527.43 | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 | Upgrade |
Free Cash Flow Per Share | 3.81 | 2.94 | 1.44 | 1.02 | 2.12 | 1.34 | Upgrade |
Gross Margin | 67.11% | 67.46% | 69.62% | 74.30% | 75.03% | 72.44% | Upgrade |
Operating Margin | 17.66% | 17.51% | 17.44% | 23.18% | 20.34% | 14.63% | Upgrade |
Profit Margin | 13.58% | 4.09% | 7.83% | 18.59% | 15.57% | 12.96% | Upgrade |
Free Cash Flow Margin | 20.08% | 16.08% | 10.53% | 10.21% | 22.90% | 17.13% | Upgrade |
EBITDA | 735.49 | 695.05 | 418.24 | 305.4 | 264.73 | 178.35 | Upgrade |
EBITDA Margin | 28.00% | 27.59% | 26.66% | 29.86% | 27.63% | 22.60% | Upgrade |
D&A For EBITDA | 271.64 | 254.02 | 144.73 | 68.25 | 69.87 | 62.87 | Upgrade |
EBIT | 463.84 | 441.03 | 273.51 | 237.15 | 194.86 | 115.47 | Upgrade |
EBIT Margin | 17.66% | 17.51% | 17.44% | 23.18% | 20.34% | 14.63% | Upgrade |
Effective Tax Rate | 4.52% | 14.69% | 25.71% | 21.75% | 17.30% | 18.76% | Upgrade |
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.